GlassScriptPhysician profile
Anowar Hossain
NPI 1942418090
$903.93
in general payments reported to CMS, 2019-2025
13 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.57 · 2022: $261 · 2023: $69.28 · 2024: $103 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545 · Education: $17.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.15 |
| Education | $17.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $142.77 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $134.99 | 2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $114.44 | 2021-2022 | |
| Axsome Therapeutics, INC. | $112.56 | 2025 | Symbravo |
| Abbvie INC. | $108.48 | 2022-2023 | |
| Lundbeck LLC | $103.32 | 2024 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $51.87 | 2022 | |
| Eisai INC. | $31.19 | 2022 | |
| Ucb, INC. | $28.50 | 2023 | Briviact |
| Alexion Pharmaceuticals, INC. | $24.89 | 2023 | Ultomiris |
| Neurelis, INC. | $17.88 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.52 | 2022 | |
| Sk Life Science, INC. | $15.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anowar Hossain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.